162 related articles for article (PubMed ID: 27249089)
1. Impact of anxious symptoms and comorbid anxiety disorders on functional impairment in depressed patients.
Culpepper L
J Clin Psychiatry; 2016 May; 77(5):e604. PubMed ID: 27249089
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
3. A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder.
Zimmerman M; Chelminski I; Young D; Dalrymple K; Walsh E; Rosenstein L
J Clin Psychiatry; 2014 Jun; 75(6):601-7. PubMed ID: 24813209
[TBL] [Abstract][Full Text] [Related]
4. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment.
Löwe B; Spitzer RL; Williams JB; Mussell M; Schellberg D; Kroenke K
Gen Hosp Psychiatry; 2008; 30(3):191-9. PubMed ID: 18433651
[TBL] [Abstract][Full Text] [Related]
5. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
Vaccarino AL; Evans KR; Sills TL; Kalali AH
Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
[TBL] [Abstract][Full Text] [Related]
6. Comorbid anxiety disorders in late-life depression: results of a cohort study.
van der Veen DC; van Zelst WH; Schoevers RA; Comijs HC; Voshaar RC
Int Psychogeriatr; 2015 Jul; 27(7):1157-65. PubMed ID: 25370017
[TBL] [Abstract][Full Text] [Related]
7. The comorbidity of anxiety and depression.
Rodney J; Prior N; Cooper B; Theodoros M; Browning J; Steinberg B; Evans L
Aust N Z J Psychiatry; 1997 Oct; 31(5):700-3. PubMed ID: 9400876
[TBL] [Abstract][Full Text] [Related]
8. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
9. Defining anxious depression in later life: a scaring heterogeneity in results.
van der Veen DC; Comijs HC; van Zelst WH; Schoevers RA; Oude Voshaar RC
Am J Geriatr Psychiatry; 2014 Nov; 22(11):1375-8. PubMed ID: 24703569
[TBL] [Abstract][Full Text] [Related]
10. Fatigue in female patients with major depression: the effect of comorbid anxiety disorders.
Ferentinos P; Kontaxakis VP; Havaki-Kontaxaki BJ; Dikeos D; Papadimitriou GN; Lykouras L
Psychiatriki; 2011; 22(4):320-9. PubMed ID: 22271845
[TBL] [Abstract][Full Text] [Related]
11. Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment.
Choi KW; Kim YK; Jeon HJ
Adv Exp Med Biol; 2020; 1191():219-235. PubMed ID: 32002932
[TBL] [Abstract][Full Text] [Related]
12. Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes?
Halbreich U; Kahn LS
J Affect Disord; 2007 Sep; 102(1-3):245-58. PubMed ID: 17092565
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders.
Brown C; Schulberg HC; Madonia MJ; Shear MK; Houck PR
Am J Psychiatry; 1996 Oct; 153(10):1293-300. PubMed ID: 8831437
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up.
Knekt P; Lindfors O; Härkänen T; Välikoski M; Virtala E; Laaksonen MA; Marttunen M; Kaipainen M; Renlund C;
Psychol Med; 2008 May; 38(5):689-703. PubMed ID: 18005493
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and correlates of major depressive disorder in individuals with body dysmorphic disorder.
Phillips KA; Didie ER; Menard W
J Affect Disord; 2007 Jan; 97(1-3):129-35. PubMed ID: 16893571
[TBL] [Abstract][Full Text] [Related]
16. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.
Melartin TK; Haukka J; Rytsälä HJ; Jylhä PJ; Isometsä ET
J Clin Psychiatry; 2010 Mar; 71(3):287-95. PubMed ID: 20079331
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
[TBL] [Abstract][Full Text] [Related]
18. Do comorbid anxiety disorders impact treatment planning for outpatients with major depressive disorder?
Petersen T; Andreotti CF; Chelminski I; Young D; Zimmerman M
Psychiatry Res; 2009 Aug; 169(1):7-11. PubMed ID: 19596155
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the diagnostic clues of depression and GAD: the primary care challenge.
den Boer JA; Evans DL; Lee S; Salin-Pascual R
Psychopharmacol Bull; 2002; 36 Suppl 2():150-7. PubMed ID: 12490831
[TBL] [Abstract][Full Text] [Related]
20. [Anxiety as a concomitant symptom of depression in the elderly].
Adler G; Brassen S; Schnitzler M; Adocchio P; Bramesfeld A
Fortschr Neurol Psychiatr; 2000 Jan; 68(1):12-6. PubMed ID: 10705570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
